Cancer Drug Combination ‘Shrinks 60% of Melanomas’
Hope in the fight against one of the most aggressive forms of cancer.
A pair of cancer drugs can shrink tumours in nearly 60% of people with advanced melanoma, a new trial has suggested.
An international trial on 945 patients found treatment with ipilimumab and nivolumab stopped the cancer advancing for nearly a year in 58% of cases.
UK doctors presented the data at the American Society of Clinical Oncology.
Cancer Research UK said the drugs deliver a “powerful punch” against one of the most aggressive forms of cancer.
Harnessing the immune system is a rapidly developing field in cancer research.
The immune system is a powerful defence against infection. However, there are many “brakes” built in to stop the system attacking our own tissues.
Cancer – which is a corrupted version of healthy tissue – can take advantage of these brakes to evade assault from the immune system.
Read the article “Cancer Drug Combination ‘Shrinks 60% of Melanomas’” on bbc.com.
